Contact: Cathia Falvey, (914) 740-2100, firstname.lastname@example.org
Rare Subset of Diseases Involving the Lymphatic System Is Focus of Special Issue of Lymphatic Research and Biology
New Rochelle, NY, February 8, 2012—A clinically challenging and under-studied subset of diseases affecting the lymphatic system and grouped under the disease spectrum lymphangiomatosis and Gorham’s disease is the focus of a special issue of Lymphatic Research and Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc. The issue is available free online.
Guest Editor, and Journal Associate Editor Francine Blei MD, MBA, St. Luke’s Roosevelt Hospital, NY, has compiled a collection of articles that highlight the complex characteristics of these diseases, which can be localized, affect multiple sites, or be systemic, may be congenital or acquired, and may cause symptoms that range from mild to severe to life-threatening. The articles focus on current knowledge, ongoing research, and how these diseases differ from other lymphatic disorders.
“This disease spectrum affects a patient population that is small in number, but the effects of the disease(s) are devastating,” says Stanley G. Rockson, MD, Editor-in-Chief of Lymphatic Research and Biology and Allan and Tina Neill Professor of Lymphatic Research and Medicine, Stanford University School of Medicine, CA. The collection of articles in this special issue, “highlights the current state of knowledge (and ignorance) in this paradoxically neglected area of lymphatic health and disease.”
Lymphatic Research and Biology is an authoritative peer-reviewed journal published quarterly in print and online that delivers the latest developments and advances in lymphatic biology and pathology from the world’s leading biomedical investigators. Topics covered include vasculogenesis and angiogenesis, genetics of lymphatic disorders, human lymphatic disease, tumor biology and metastasis, pharmacology, lymphatic imaging, and inflammation, infection, and autoimmune disease. Complete tables of content and a sample issue may be viewed online.
Mary Ann Liebert, Inc. is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Cancer Biotherapy and Radiopharmaceuticals and DNA and Cell Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 70 journals, books, and newsmagazines is available at our website.